A Randomized, Parallel Group, Open Label, to Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD06 Cream Versus Comp01 Cream in Subjects With Moderate to Severe Plaque Psoriasis
Phase of Trial: Phase II
Latest Information Update: 03 Oct 2016
At a glance
- Drugs DFD 06 (Primary) ; Corticosteroid
- Indications Plaque psoriasis
- Focus Adverse reactions
- Sponsors Promius Pharma
- 01 Aug 2016 Status changed from active, no longer recruiting to completed.
- 13 May 2016 Planned End Date changed from 1 Apr 2016 to 1 Jun 2016.
- 09 Mar 2016 Planned End Date changed from 1 Feb 2016 to 1 Apr 2016, as reported by clinicalTrials.gov record.